Delivery Order SPE2DB22D1002-SPE2DB24FKWR0
Award Date 1/18/24
Potential Completion Date 1/19/24
Potential Value $14K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,558,234,757 vials of the M-M-R II vaccine. The $108,872.80 contract has a completion date of August 26, 2022. Amerisourcebergen Drug Corp, a for-profit organization, will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is part of Amerisourcebergen's broader work providing...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply M-M-R II vaccine vials. The contract has a potential value of $2,561.90 and a completion date of January 11, 2024. This delivery order is part of Amerisourcebergen's broader contract with DLA Troop Support Medical to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,542.17 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 22, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 23, 2026. AmerisourceBergen Drug Corp operates as a subsidiary...
- The Defense Logistics Agency awarded a $1,177.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with a completion date of January 22, 2026. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $7,720.60 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 19, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued as a child contract under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,766.37 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 29, 2026, with an ultimate completion date of January 30, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $8,798.16 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the provision of M-M-R II vaccine vials, with a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA with a...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $4,556.17 to Amerisourcebergen Drug Corporation for M-M-R II vaccine vials. As the prime contractor, Amerisourcebergen will deliver the vaccines to its place of performance in Conshohocken, Pennsylvania by September 11, 2023 to fulfill the agency's requirement. The parent company, Amerisourcebergen Corporation, will support performance through its corporate office and division. No major subcontractors or set aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for M-M-R II vaccine vials valued at $2,939.10. This competitively awarded, firm fixed-price contract is scheduled for completion by July 23, 2025, with performance to be conducted at the vendor's corporate office location in Conshohocken, PA. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,260.96 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with a completion date of September 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies Conshohocken, Pennsylvania as the place of performance, which is also AmerisourceBergen's corporate headquarters location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FKWR0Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation, to supply 4,563,356,844 units of the M-M-R II vaccine in Conshohocken, Pennsylvania. The $14,346.64 delivery order has a completion date of January 19, 2024 and was awarded on January 18, 2024. AmerisourceBergen Drug Corporation is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This award is part of DLA's medical supplies and pharmaceuticals programs and does not have a set-aside designation.
Generated 4/18/24, 12:17 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 1/18/24 |